Thermo Fisher Scientific Expands Pharma Division in Greenville, North Carolina
03/20/2019
According to company officials the expansion will provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing.
Included in the site expansion projects are Monza and Ferentino, Italy, and Greenville, North Carolina. In response to customer requests, each of the sites will be equipped with aseptic filling lines and isolator technology. Construction is expected to be completed within the next 24 months.
"These investments will help expand our global sterile manufacturing network and meet the increasing demand from customers that rely on our biologics development and manufacturing expertise," said Michel Lagarde, President of pharma services for Thermo Fisher Scientific.
"We continue to invest to expand our capabilities and help our customers deliver the highest quality medicines to the patients who need them,” Lagarde added.
Accela Expands Operations in Draper, Utah
05/21/2019
Most Read
-
-
2018 Leading Metro Locations: Pacific and Mountain Metros Dominate the List
Q2 2018
-
33rd Annual Corporate Survey & the 15th Annual Consultants Survey
Q1 2019
-
2018 Top States for Doing Business: Georgia Ranks #1 Fifth Year in a Row
Q3 2018
-
Opportunity Zones Can Uplift Communities and Investors Alike
Q2 2019
-
Made in America: An Outlook for Manufacturing in the U.S.
Location USA 2018
-
A Changing Food Manufacturing Industry
2017 Food Processing